Hot Features
Premium
Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 2,583 |
|
|||||
| News | - | ||||||
| Day High | 2.93 | Low High |
|||||
| Day Low | 2.86 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Acasti Pharma Inc | ACST | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.0285 | 0.98% | 2.9285 | 15:02:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 2.86 | 2.86 | 2.93 | 2.9285 | 2.90 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 60 | 2,583 | US$ 2.87 | US$ 7,418 | - | 1.72 - 3.84 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:17:29 | 5 | US$ 3.03 | USD |
Acasti Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.45M | 9.40M | - | 0 | -42.43M | -4.51 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Acasti Pharma News
| Date | Time | Source | News Article |
|---|---|---|---|
| 2/12/2024 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/12/2024 | 06:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 1/08/2024 | 07:00 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 1/08/2024 | 06:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/20/2023 | 15:08 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/20/2023 | 15:08 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/20/2023 | 15:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/15/2023 | 06:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/13/2023 | 06:30 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 10/23/2023 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/16/2023 | 15:31 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 10/11/2023 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACST Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.17 | 3.19 | 2.81 | 2.91 | 10,475 | -0.2415 | -7.62% |
| 1 Month | 3.42 | 3.50 | 2.81 | 3.32 | 17,960 | -0.4915 | -14.37% |
| 3 Months | 2.47 | 3.59 | 2.25 | 3.22 | 27,508 | 0.4585 | 18.56% |
| 6 Months | 2.37 | 3.59 | 1.98 | 2.90 | 24,357 | 0.5585 | 23.57% |
| 1 Year | 2.88 | 3.84 | 1.72 | 2.90 | 46,950 | 0.0485 | 1.68% |
| 3 Years | 2.8806 | 17.6352 | 1.72 | 3.91 | 1,579,970 | 0.0479 | 1.66% |
| 5 Years | 5.46 | 18.48 | 1.026 | 4.18 | 4,909,158 | -2.53 | -46.36% |
Acasti Pharma Description
| Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all which could help to increase treatment compliance and improve patient outcomes. |
